Piramal Pharma witnessed a positive surge of more than 5% in its shares on Thursday following the receipt of an ‘Establishment Inspection Report’ (EIR) from...
Shares of Piramal Pharma plunged nearly 13% in early trading on Thursday after the company reported weak earnings for the December 2022 quarter. The pharmaceutical...